Turing Pharmaceuticals decreasing Daraprim drug price after outrage
Wednesday, September 23, 2015 - 07:00
in Mathematics & Economics
Andrew V. PestanoWASHINGTON, Sept. 23 (UPI) -- The CEO of Turing Pharmaceuticals said he will reduce the price for Daraprim, used to treat toxoplasmosis, after outrage over a 5,000 percent price increase.